Innovation portfolio

Maculaser

Maculaser’s pioneering retinal treatment triggers the natural healing response of senescent cells with personalized heat exposure. Targeting disease prevention, we offer a patient-specific, non-damaging solution to retinal disorders affecting millions worldwide.

Status:

Startup company

SDGs:

Good health and well-being

Industry:

Life science and medical

Impact:

Quality of life

Origin:

School:

School of Science

Established:

2020

The core objective of non-damaging retinal heating is to harness the regenerative effects associated with temperature elevation, promoting healing without causing harm to delicate retinal tissues. Maculaser’s solution employs retinal temperature monitoring designed to ensure safe, effective, and consistent treatments for every patient, taking into account inter-patient variability and differences across retinal locations.

See all